Fischer Medical Ventures Limited has disclosed the outcome of its Board meeting held on May 29, 2026. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board of Directors recommended a final dividend of 5%, which translates to ₹0.05 (Five Paise only) per equity share. The shares have a face value of ₹1 each. This dividend recommendation is for the financial year ended March 31, 2026.
The dividend payment is contingent upon declaration and approval by the shareholders at the ensuing Annual General Meeting (AGM). If approved, the company will pay or dispatch the dividend within 30 days from the date of the AGM.
The letter was signed by Balaji Gandla, Company Secretary and Compliance Officer, requesting the exchanges to take this information on record.